Physician
Otterbeck, Robert
Otterbeck, Robert was paid $4K by Medicaid between Dec 2022 and Oct 2023, across 4 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 100% of everything it billed.
33Billing provider infoOTTERBECK, ROBERT
NEW YORK, NY 10065
NEW YORK, NY 10065
33aNPI1487064077assigned 05/05/2014
33bProvider typePain Medicine (Anesthesiology) Physician
28Total paid$4K
24GClaims428
24DCodes billed4
24AFirst – last monthDec 2022 – Oct 2023
Compared with peers
Next to other Pain Medicine (Anesthesiology) Physician providers in New York
Rank by total paid#90 of 125
Median peer was paid$14K
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 24 | $191.24 | |
| 2023 | 404 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 100% | 141 | 135 | $4K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 184 | 175 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 75 | 72 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 28 | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.